Prothena Corp Public (PRTA) Non Operating Income (2013 - 2026)

Prothena Corp Public's (PRTA) quarterly Non Operating Income came in at $2.7 million in Q1 2026, down 36.15% year-on-year from $4.2 million in Q1 2025, and up 2.4% quarter-over-quarter from $2.6 million in Q4 2025.

Prothena Corp Public (PRTA) Non Operating Income (2013 - 2026) Analysis & Trends

Prothena Corp Public's Non Operating Income history runs 14 years deep, the most recent figure standing at $2.7 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 36.15% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $12.3 million, a 45.98% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, down 46.12% from the prior year.
  • Non Operating Income rose to $2.7 million in Q1 2026 per PRTA's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $8.5 million in Q3 2023 and bottomed at -$17000.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $4.2 million (2025), against an average of $4.6 million.
  • Biggest YoY gain for Non Operating Income was 85525.0% in 2022; the steepest drop was 150.0% in 2022.
  • Year by year, Non Operating Income stood at $3.4 million in 2022, then jumped by 131.11% to $7.9 million in 2023, then tumbled by 31.67% to $5.4 million in 2024, then slumped by 51.37% to $2.6 million in 2025, then advanced by 2.4% to $2.7 million in 2026.
  • Per Business Quant, the three latest PRTA Non Operating Income figures stand at $2.7 million (Q1 2026), $2.6 million (Q4 2025), and $3.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Prothena Corp Public 467.80 Mn 138.33 Mn - 2.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.69 Mn
Dec 31, 2025 2.62 Mn
Sep 30, 2025 3.33 Mn
Jun 30, 2025 3.65 Mn
Mar 31, 2025 4.21 Mn
Dec 31, 2024 5.40 Mn
Sep 30, 2024 6.68 Mn
Jun 30, 2024 6.47 Mn
Mar 31, 2024 7.09 Mn
Dec 31, 2023 7.90 Mn
Sep 30, 2023 8.51 Mn
Jun 30, 2023 7.60 Mn
Mar 31, 2023 6.55 Mn
Dec 31, 2022 3.42 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 637,000.00
Mar 31, 2022 -17,000.00
Dec 31, 2021 -4,000.00
Sep 30, 2021 -31,000.00
Jun 30, 2021 -53,000.00